The 20 Best Encephalitis Doctors Near Me in Salisbury, MD

Dr. Probasco is a professor at the Johns Hopkins University School of Medicine Department of Neurology. He is the Vice Chair for Quality, Safety, and Service for the department. He also serves as the Director of the Johns Hopkins Division of Advanced Clinical Neurology as well as the Medical Director of the Johns Hopkins Inpatient General Neurology Service. He co-directs the Johns Hopkins Encephalitis Center and the Johns Hopkins Center for Refractory Status Epilepticus and Neuroinflammation. He cares for general neurology inpatients and outpatients, specializing in autoimmune and paraneoplastic syndromes as well as neurological immune-related adverse events following immunotherapies for cancer. After completing his undergraduate studies in biochemistry at the University of New Mexico, Dr. Probasco attended the University of Oxford as a Rhodes Scholar and earned a second undergraduate degree in psychology, philosophy and physiology. He went on to earn his medical degree at the University of California, San Francisco. He completed an internship in internal medicine at Johns Hopkins Bayview Medical Center and a residency in neurology at Johns Hopkins, where he was the faculty liaison/executive chief resident. He went on to complete an instructorship in inpatient general neurology at Johns Hopkins. Dr. Probasco’s research interests include increasing care value through improving outcomes, incorporation of patient experience of disease and treatment, the efficiency of care delivery, and diagnostic test utilization in general and specifically in relation to autoimmune and paraneoplastic neurological syndromes, including encephalitis. Finally, he is interested in the management of neurological immune-related adverse events following immunotherapies for the treatment of cancer. Dr. Probasco has been recognized at the departmental, institutional, and national levels for teaching and clinical excellence, including the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Frank L. Coulson, Jr. Award from the Johns Hopkins Medicine Miller-Coulson Academy of Clinical Excellence. He is a past graduate of the Johns Hopkins Armstrong Institute Resident Scholars (AIRS) program in Patient Safety and Quality. As a faculty member, he was inducted into the Miller-Coulson Academy of Clinical Excellence in 2019. He serves as Editor-in-Chief of NEJM Journal Watch Neurology. Videos The impact of COVID-19 on the Department of Neurology‚Äôs clinical care and medical education programs. Dr. Probasco is rated as an Elite provider by MediFind in the treatment of Encephalitis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Encephalitis, Anti-NMDA Receptor Encephalitis, Status Epilepticus, Creutzfeldt-Jakob Disease, and Gastrostomy. Dr. Probasco is board certified in American Board Of Psychiatry And Neurology.

Dr. Arun Venkatesan serves as Director of the Johns Hopkins Encephalitis Center, where he directs clinical activities and research. At the center he has developed a multidisciplinary program devoted to optimizing diagnosis and management of patients with infectious and autoimmune encephalitis and understanding mechanisms of disease in order to develop more effective treatments. He also plays an active role in the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers. He received his undergraduate degree in biomedical engineering from the University of California, Berkeley in 1994, followed by a Ph.D. in microbiology and immunology and an M.D. from the University of California, Los Angeles. He completed his residency in neurology and fellowship in neuroinfectious and neuroinflammatory diseases at Johns Hopkins, after which he was appointed to the faculty in the department of neurology in 2007. His laboratory research focuses on defining causes and mechanisms of central nervous system injury in the setting of infection and neuroinflammation, with a goal towards developing protective and regenerative strategies. He has received funding from the National Institutes of Health, Howard Hughes Medical Institute, National Multiple Sclerosis Society, and Maryland Stem Cell Research Fund. Dr. Venkatesan is rated as an Elite provider by MediFind in the treatment of Encephalitis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Encephalitis, Herpes Simplex Encephalitis, Anti-NMDA Receptor Encephalitis, and Multiple Sclerosis (MS). Dr. Venkatesan is board certified in American Board Of Psychiatry And Neurology.

Avindra Nath is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Nath is rated as an Elite provider by MediFind in the treatment of Encephalitis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Progressive Multifocal Leukoencephalopathy, Encephalitis, CACH Syndrome, and Stroke.

Irene Cortese is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Cortese is rated as an Elite provider by MediFind in the treatment of Encephalitis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Progressive Multifocal Leukoencephalopathy, CACH Syndrome, Encephalitis, and Multiple Sclerosis (MS).

Neurologist Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He works within the Division of Neuroimmunology and Neurological Infections at The Johns Hopkins Hospital, and has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica and stiff person syndrome. After completing fellowship training, Dr. Newsome joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, and he is the director of the Johns Hopkins Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center. He is also director of the Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program and co-director of the Multiple Sclerosis Experimental Therapeutics Program. Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine, with honors. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award, and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship Award from the National Multiple Sclerosis Society. Identifying and testing novel therapies and therapeutic strategies for multiple sclerosis and other neuroimmunological disorders is Dr. Newsome’s main research focus. Other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. An adviser for the National Multiple Sclerosis Society and a member of the Miller-Coulson Academy of Clinical Excellence, Dr. Newsome has also served as president of the Consortium of Multiple Sclerosis Centers. Dr. Newsome is rated as an Advanced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS). Dr. Newsome is board certified in American Board Of Psychiatry And Neurology.

Dr. Justin McArthur is nationally and internationally recognized for his work in studying the natural history, development and treatment of the neurological complications of HIV/AIDS, multiple sclerosis and other neurological infections and immune-mediated neurological disorders. Dr. McArthur has also developed a technique to use cutaneous nerves to study sensory neuropathies, including those associated with chemotherapy, HIV and diabetes. Currently his clinical practice includes neuroimmunological disorders including MS, neurological infections, and complex undiagnosed neurological disorders. Dr. McArthur was the founding director of the Johns Hopkins/National Institute of Mental Health Research Center for HIV-associated Cognitive Disorders. The Center is an experienced interdisciplinary research team who have pooled their talents to study the nature of HIV-associated cognitive disorders. he is also the founding director of the Johns Hopkins Sheikh Khalifa Stroke institute. Dr. McArthur received his medical degree from Guys Hospital Medical School in London, UK. He then completed an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore, MD. Dr. McArthur stayed with Johns Hopkins to complete a residency in neurology and achieve his Master's in public health. He is the current Director of the Johns Hopkins Department of Neurology and holds the John W. Griffin Professorship in neurology which was established in 2015 by Jeffrey and Harriet Legum. In April 2017 Dr. McArthur was elected to the Association of American Physicians. In 2020 he was inducted into the National Academy of Medicine. Dr. Mcarthur is rated as an Advanced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Progressive Multifocal Leukoencephalopathy, Relapsing Multiple Sclerosis (RMS), and Encephalitis. Dr. Mcarthur is board certified in American Board Of Psychiatry And Neurology and American Board Of Internal Medicine.

Dr. Romergryko G. Geocadin is a professor of neurology, of neurosurgery and of anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in medicine. He completed his medical education in the Philippines, residency at NYU and fellowship at Johns Hopkins, and now specializes in neurocritical care medicine at Johns Hopkins. Presently, he is the chairman of the multidisciplinary critical care practice committee at Johns Hopkins Bayview and co-director of the Johns Hopkins Encephalitis Center. Previously, he was director of the Neurosciences Critical Care Unit at Johns Hopkins Bayview and director of the Division of Neurosciences Critical Care at Johns Hopkins. As a member of the Science Committee of the Emergency Cardiovascular Care Committee of the American Heart Association (AHA) and the Adult Research Task Force of the Get with the Guidelines Resuscitation, he has published several AHA statements, guidelines and high-impact scientific articles related to cardiac arrest resuscitation. Dr. Geocadin was a panelist and speaker for the Institute of Medicine (IOM) of the National Academy of Sciences Committee on Treatment of Cardiac Arrest: Current Status and Future Directions. He is chair of the practice guidelines writing group on Brain Injury and Cardiac Arrest for the American Academy of Neurology. Dr. Geocadin has published extensively in peer-reviewed journals, and he serves on the editorial boards of Resuscitation, Neurocritical Care, Seminars in Neurology, and Critical Care Practice and Research. He was guest editor for Neurology Clinics, Critical Care Clinics, and Emergency Medicine Clinics of North America. He has been elected fellow of the American Academy of Neurology, American Neurological Association and the Neurocritical Care Society. He is the president-elect of the Neurocritical Care Society (NCS) and chairman of the 2014 Annual Meeting of the NCS. Dr. Geocadin is rated as an Advanced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Brain Herniation, Encephalitis, Status Epilepticus, Seizures, and Gastrostomy. Dr. Geocadin is board certified in American Board Of Psychiatry And Neurology.

Brenda Banwell is the director of the Department of Pediatrics, as well as pediatrician-in-chief and co-director of Johns Hopkins Children’s Center, where she helps manage the hospital’s many clinical and research centers. Dr. Banwell is a renowned expert in the research and treatment of pediatric multiple sclerosis (MS) and other neuroimmune disorders. She specializes in and studies the use of neuroimaging to assess the clinical and cognitive impact of the conditions, as well as the function of the immune system in children with these disorders. She also created a standardized clinical care algorithm and clinical database in order to evaluate the clinical impact of MS. Dr. Banwell has published more than 250 manuscripts in high-impact journals, along with over 25 book chapters. In addition, she has over 200 national and international invited lectureships and visiting professorships. An advocate for pediatric multiple sclerosis needs and research, Dr. Banwell serves as chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation, and the Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD) International Research Consortium. She is also chair of the pediatric committee of the National Institutes of Health NeuroNEXT program, which conducts studies on treatments for neurological diseases through academic, private, and industry collaborations. Dr. Banwell currently serves as past-chair of the International Pediatric Multiple Sclerosis Study Group, Dr. Banwell earned her medical degree from the University of Western Ontario. She later completed a residency in pediatrics at the University of Western Ontario-Children's Hospital of Western Ontario and a second residency in pediatric neurology at University of Toronto – The Hospital for Sick Children. Her residencies were followed by a fellowship in neuromuscular research at Mayo Clinic. Dr. Banwell is rated as an Advanced provider by MediFind in the treatment of Encephalitis. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis. Dr. Banwell is board certified in Royal College Of Physicians And Surgeons Of Canada.

Dr. Peter Kaplan is Professor of Neurology and serves as the Director of Epilepsy and EEG at Johns Hopkins Bayview Medical Center. He focuses on epilepsy, clinical neurophysiology and nonconvulsive status epilepticus. He has written extensively about these subjects as well as about eclampsia and neurologic disease in women. Dr. Peter Kaplan received his medical training from St. Bartholomews Medical School, University of London. He then obtained membership to the Royal College of Physicians in England. He completed his residency in neurology at Duke University Medical Center. He completed fellowships in epilepsy and clinical neurophysiology at the same institution. Dr. Kaplan currently sees patients at the Johns Hopkins Bayview Medical Center on Tuesdays and Wednesdays. Dr. Kaplan is rated as an Advanced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Status Epilepticus, Epilepsy, and Awake Craniotomy. Dr. Kaplan is board certified in American Board Of Psychiatry And Neurology.

Ilana Kahn is a Pediatric Neurologist practicing medicine in Silver Spring, Maryland. Dr. Kahn is rated as a Distinguished provider by MediFind in the treatment of Encephalitis. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Anti-NMDA Receptor Encephalitis, Encephalitis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Landau-Kleffner Syndrome.

Richard Choi is a Neurologist practicing medicine in Glen Burnie, Maryland. He has been practicing medicine for over 18 years. Dr. Choi is rated as an Experienced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Stroke, Apoplexy, Subarachnoid Hemorrhage, Stent Placement, and Transmyocardial Revascularization.

Dr. Adam Hartman is an Adjunct Associate Professor of Neurology and Pediatrics at Johns Hopkins School of Medicine. He focuses on treating children with epilepsy, with an emphasis on those whose seizures have not been adequately controlled with medication. He evaluates and manages patients in his clinic who may be candidates for epilepsy surgery, including those with Rasmussen syndrome, brain malformations, and perinatal strokes. Patients who may not be surgery candidates due to inborn errors of metabolism (particularly mitochondrial disorders) also are a special interest for Dr. Hartman. Dr. Hartman is currently a Physician at NINDS/NIH, serving as a Program Director in the Division of Clinical Research. Previously, Dr. Hartman was the Associate Program Director for the Pediatric Neurology Residency at Johns Hopkins Hospital. He also was the Co-Director of the Neurology Intensive Care Nursery and an Attending Physician on the Pediatric Neurology Inpatient Service at Johns Hopkins Hospital. Dr. Hartman’s prior laboratory work was funded by National Institute of Neurological Disorders and Stroke (NIH), Technology Development Corporation (State of Maryland), a Johns Hopkins University School of Medicine Clinician Scientist Award, the Pakula Family, and the Becker Family. Dr. Hartman received his medical degree from Northwestern University Medical School. After completing his residency in Pediatrics in the National Capital Uniformed Services Pediatric Residency Program (National Naval Medical Center, Walter Reed Army Medical Center), he served as a general pediatrician in the US Navy for five years (the last as division head of general pediatrics at Naval Medical Center San Diego). He completed his residency in pediatric neurology and a fellowship in clinical neurophysiology/pediatric epilepsy, both at Johns Hopkins. Dr. Hartman is rated as an Experienced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Hemimegalencephaly, Seizures, Epilepsy, and Increased Head Circumference. Dr. Hartman is board certified in American Board Of Psychiatry And Neurology.

Khalil Husari, M.D., is a neurologist with expertise in epilepsy, electroencephalography (EEG), and neurophysiology. He specializes in treating patients with seizures and epilepsy, presurgical evaluation for and the management of drug-resistant epilepsy, and the acute and chronic management of patients with status epilepticus. Additionally, he specializes in intraoperative neuromonitoring and is the director of the Intraoperative Neurophysiological Monitoring (IONM) Unit. Dr. Husari earned his medical degree from the University of Jordan School of Medicine, then completed his residency in neurology at the University of Texas Southwestern Medical Center, where he served as a chief resident during his final year. Dr. Husari continued his training as an epilepsy fellow at the Johns Hopkins University School of Medicine. Dr. Husari is rated as an Experienced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Seizures, Status Epilepticus, Epilepsy, Generalized Tonic-Clonic Seizure, and Osteotomy. Dr. Husari is board certified in American Board Of Psychiatry And Neurology.

Dr. Rafael Llinas serves as the Director of Neurology at the Johns Hopkins Bayview Medical Center. His clinical interests include acute stroke treatments, neurovascular imaging and migraine as related to cerebrovascular disease. He also serves as the associate director of the neurology residency program. He was instrumental in establishing the Johns Hopkins Bayview Medical Center Stroke Center. In 2005, in recognition of the Stroke Centers organizational efforts in stroke care, the institution was granted certification as a Primary Stroke Center by the Joint Commission on Accreditation of Healthcare Organizations. Dr. Llinas primary areas of research interests include diffusion-perfusion imaging of stroke, intravenous and intra-arterial thrombolysis for stroke, education of physicians and nurses in stroke identification and stroke care, stroke units and stroke centers. Dr. Rafael Llinas received his medical degree from the New York University School of Medicine. He completed a medical internship at the Boston City Hospital and was a neurology resident in the Harvard-Longwood neurology training program. Following his residency, he was a stroke and cerebrovascular disease fellow for two years at Beth Israel Hospital, Harvard University. Dr. Llinas is rated as an Experienced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Stroke, Cerebral Amyloid Angiopathy, Siderosis, Thrombectomy, and Gastrostomy. Dr. Llinas is board certified in American Board Of Psychiatry And Neurology.

Paul Nyquist is a Neurologist and an Anesthesiologist practicing medicine in Baltimore, Maryland. Dr. Nyquist is rated as an Experienced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Stroke, Subarachnoid Hemorrhage, CACH Syndrome, Apoplexy, and Thrombectomy. Dr. Nyquist is board certified in American Board Of Psychiatry And Neurology.

A leading expert on brain injury, Dr. Daniel F. Hanley has been a professor of neurology, neurosurgery, and anesthesiology/critical care medicine at the Johns Hopkins University School of Medicine since 1996 and was named the Jeffrey and Harriet Legum Chair of Acute Care Neurology. Dr. Hanley founded and directed the Johns Hopkins Neurocritical Care Unit, one of the first critical care units dedicated solely to neurosurgical and neurological patients. Subsequently, in 1999, he founded and continues to direct the BIOS Clinical Trials Coordinating Center (BIOS CTCC), formerly known as the Division of Brain Injury Outcomes. Under Dr. Hanley’s leadership, BIOS CTCC, an academic contract research organization based at Johns Hopkins, has organized and completed more than 20 large clinical trials. He has been awarded over 70 clinical and basic research grants, predominantly from the National Institutes of Health and the FDA Orphan Products Grants Program. Dr. Hanley’s 40-year career in medicine has focused on clinical trial design, the organization and interpretation of drug and device trials, the development of strategic research plans, and FDA regulatory compliance. He has led international, NIH-sponsored trials including the MISTIE III and CLEAR III trials investigating minimally invasive neurosurgical techniques to treat hemorrhagic stroke. As principal investigator for the National Center for Advancing Translational Sciences (NCATS) Johns Hopkins Trial Innovation Center, Dr. Hanley leads collaborative efforts to advance education and therapeutics through innovative CTSA clinical trials. Currently, Dr. Hanley is the PI or multi-PI for several ongoing trials. These include a multisite phase 2/3 randomized controlled dementia prevention trial (MAP), a large multicenter clinical trial involving automated monitoring of atrial fibrillation (REACT AF), and a first-in-patient phase 2a biomarker and edema attenuation in intracerebral hemorrhage trial (BEACH). Dr. Hanley has published over 400 peer-reviewed articles and book chapters, received the Humboldt Research Prize for accomplishments in brain injury research, and mentored nearly 100 researchers. His trainees, which include a large number of trialists, have led 25 brain intensive care units, and over 40 have been named full professors, program leaders, or department chairs. He has served on public boards including the American Academy of Neurology, National Stroke Association, and NIH National Institute of Nursing Research. Dr. Hanley is rated as an Experienced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Stroke, Hydrocephalus, Vertigo, Thrombectomy, and Gastrostomy. Dr. Hanley is board certified in American Board Of Psychiatry And Neurology and American Board Of Internal Medicine.

David Kamson is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Kamson is rated as an Experienced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioblastoma, Metastatic Brain Tumor, Gliosarcoma, and Hormone Replacement Therapy (HRT). Dr. Kamson is board certified in American Board Of Psychiatry And Neurology.

Colleen Christmas is associate professor of medicine. Practicing geriatric medicine primary care and consultative geriatric medicine, she serves as the director of the Primary Care Leadership Track and faculty in the Colleges Advising Program at the Johns Hopkins University School of Medicine. Her academic interests include medical education, professional identity formation, nutrition and exercise in the elderly. She received her medical degree from the University of Connecticut John Dempsey Hospital. Dr. Christmas is rated as an Experienced provider by MediFind in the treatment of Encephalitis. Her clinical expertise encompasses Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Diabetic Hyperglycemic Hyperosmolar Syndrome. Dr. Christmas is board certified in American Board Of Internal Medicine.

Dr. Mackenzie Cervenka focuses on the diagnosis and treatment of patients with seizures and epilepsy, including surgical treatment and dietary therapies. She is an attending physician in the Epilepsy Monitoring Unit. Her specific interests include evaluations for seizure surgery, continuous electroencephalography in the intensive care unit, epilepsy in women (including considerations during pregnancy), and dietary therapies for adults with epilepsy. Dr. Cervenka's research focuses the efficacy of Ketogenic diets in the treatment of adults with epilepsy. She also studies brain mapping in preparation for epilepsy surgery. Dr. Cervenka completed her undergraduate studies at the University of Virginia and received her medical degree from the University of Virginia School of Medicine. She then completed her internship in internal medicine and residency in neurology at the University of Maryland Medical Center. Dr. Cervenka completed a fellowship in epilepsy and clinical neurophysiology at Johns Hopkins. Dr. Cervenka currently sees patients in The Johns Hopkins Outpatient Center on Monday and Wednesday afternoons. She also sees patients in The Johns Hopkins Adult Epilepsy Diet Center on Friday mornings once a month. Dr. Cervenka is rated as an Experienced provider by MediFind in the treatment of Encephalitis. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Epilepsy, Seizures, Lennox-Gastaut Syndrome (LGS), and Status Epilepticus. Dr. Cervenka is board certified in American Board Of Psychiatry And Neurology.

Dennis Dey, MD, specializes in neurology and is board certified in neurology and pain medicine by the American Board of Psychiatry and Neurology. He practices at UPMC Western Maryland Neurology and Proactive Pain and Neurology. Dr. Dey completed his fellowship at Massachusetts General Hospital - Harvard Medical School, residency at MCP Hahnemann University/Drexel and Universitats Augenklinik, and medical education at Freie Universitat Berlin. Dr. Dey is rated as an Experienced provider by MediFind in the treatment of Encephalitis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Cervical Spondylosis, Stroke, Headache, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Dr. Dey is board certified in American Board Of Psychiatry And Neurology and American Board Of Psychiatry And Neurology.